Medication Detail
Cinqair Reslizumab Injection
Teva-Handok wins approval for anti-asthma injection < Pharma < Article - KBR
Brand name: Auvi-Q
Help eligible, commercially insured patients save on out-of-pocket costs for CINQAIR*
Teva's severe eosinophilic asthma drug Cinqaero wins EU approval
Reslizumab | New Drug Approvals
Teva files MAA for asthma treatment reslizumab
How patients use CINQAIR® (reslizumab) Injection Cost Support Program Card
Chest Medicine Made Easy-Dr Deepu: FDA approves Injectable drug for uncontrolled Asthma
CINQAERO (reslizumab) de Teva ya está disponible en España para el asma grave no controlada | IM Farmacias
CINQAIR® (reslizumab) Injection – About Asthma Control
Predicting Responders to Reslizumab after 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Patients wit
Cinqair (Reslizumab) 100mg/10mL Injection – Apothera
761033Orig1s000
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
Reslizumab | New Drug Approvals
Reslizumab (Cinqair) Approved to Treat Severe Asthma | RT
A program supporting CINQAIR® (reslizumab) Injection patients
Reslizumab | Teva UK
Teva Announces EMA Validation of Reslizumab Marketing Authorization Application
Teva filled Biologics License Application for reslizumab Archives • NCK Pharma
Discount helps NICE flip-flop on Teva's severe asthma contender, Cinqair | Fierce Pharma
NICE changes mind and backs new drug for severe asthma | Nursing Times
Reslizumab Reslizumab | Teva | Bioz
